Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo
Crossref DOI link: https://doi.org/10.1186/s12885-017-3204-x
Published Online: 2017-03-24
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buchholz, M.
Majchrzak-Stiller, B.
Hahn, S.
Vangala, D.
Pfirrmann, R. W.
Uhl, W.
Braumann, C.
Chromik, A. M.